University of Thessaly (UTH)
Επίδραση της καφεϊνης στην κλινική εικόνα ασθενών με σχιζοφρένεια
Abstract
dc:descriptionIntroduction: Caffeine is the most consumed psychostimulant worldwide. Schizophrenia is an uncommon mental disorder affecting 0.34% of the global population. The aim of the present study was to investigate a possible association between caffeine consumption or the ratios MLR, NLR, PLR, SII (Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Systemic Immune-inflammation Index: Platelet x Neutrophil-to Lymphocyte Ratio, respectively) and the symptom profile, risky behavior and cognitive function in patients with schizophrenia. Methods: This prospective cohort study included patients diagnosed with schizophrenia who were admitted to the Psychiatry Ward or visited the Psychiatry Outpatient Clinic at the Larissa University Hospital for a period of 36 months. All patients underwent an extensive psychiatric and cognitive function assessment using the standardized Greek version of the Positive and Negative Symptom Scale (PANSS), the generalized anxiety disorder scale (GAD-7), and the Addenbrooke cognitive test (ACE-R). Blood samples were drawn for full hematological assessment and the determination of serum caffeine levels using the reversed-phase HPLC method. Results: In total, 60 patients were included in the present study. The mean age of the participants was 45 ± 11 years. The mean age at onset was 23 ± 7 years, while the mean duration of illness from age of onset was 21.58 years. Caffeine serum levels exhibited a positive correlation with the poor attention component of the general psychopathology PANSS subscale, as well as with the attention and orientation component in the ACE-R. Moreover, a positive correlation was observed between the perilous behavior PANSS subscale and caffeine serum levels. Conversely, as caffeine serum levels increased, fewer negative symptoms were reported, specifically, the poor rapport and passive/apathetic social withdrawal of the negative PANSS subscale. The MLR ratio showed a positive correlation with the hostility item of the positive scale. The NLR and SII ratios also exhibited a positive correlation with the educational disorder item of the general psychopathology scale. Conclusions: In summary, this study highlights the significant associations between caffeine serum levels, symptom severity, and cognition among patients with schizophrenia. While the findings provide valuable insights regarding the involvement of caffeine in schizophrenia, they should be interpreted with caution due to several limitations of the study. Larger scale cohort studies are required in order to elucidate the impact of caffeine consumption in patients with schizophrenia.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Janho, Michel
- Τζάνχο, Μισέλ
Subjects
dc:subject × 22- Καφεΐνη
- Επιθετικότητα και Σχιζοφρένεια
- Σχιζοφρένεια
- Αντι-φλεγμονώδεις παράγοντες
- Ανοσολογία
- Έκπτωση των Γνωστικών Λειτουργιών στη Σχιζοφρένεια
- Schizophrenia
- Caffeine
- Immunology
- Anti-inflammatory
- Cognitive Deficits in Schizophrenia
- Violence in Schizophrenia
- Βασική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Φαρμακολογία και Φαρμακευτική
- Κλινική Ιατρική
- Ψυχιατρική και Ψυχική υγεία
- Basic Medicine
- Medical and Health Sciences
- Pharmacology and Pharmacy
- Clinical Medicine
- Psychiatry and Mental Health
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/62122